Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Galcanezumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Gowling WLG (Canada) LLP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Gowling WLG (Canada) LLP

    GALCANEZUMAB
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    GALCANEZUMAB

    Brand Name : EMGALITY

    Patent Number : 2802102

    Filing Date : 2011-06-07

    Strength per Unit : 120 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Gowling WLG (Canada) LLP

    GALCANEZUMAB
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    GALCANEZUMAB

    Brand Name : EMGALITY

    Patent Number : 2802102

    Filing Date : 2011-06-07

    Strength per Unit : 120 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Gowling WLG (Canada) LLP

    GALCANEZUMAB
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Gowling WLG (Canada) LLP

    Country
    arrow
    BIO Partnering at JPM
    Not Confirmed

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    GALCANEZUMAB

    Brand Name : EMGALITY

    Patent Number : 2802102

    Filing Date : 2011-06-07

    Strength per Unit : 100 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2031-06-07

    Date Granted : 2016-07-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.